California, Orchard Therapeutics and the 'Bubble Baby' Treatment: No Progress Announced Last Week

Some sort of resolution of the Orchard Therapeutics “bubble baby” case may be in the works, but it did not surface at last week’s meeting of the board of the California stem cell agency, which has a $43 million stake in the matter. 

There were indications earlier this month that an announcement might be made at the meeting last Tuesday, but not a word wa…